https://www.selleckchem.com/pr....oducts/pemigatinib-i
The biological dosimetry assays and EPR techniques proved to be most applicable in cases when the radionuclides are almost homogeneously distributed in the body. No compelling evidence was obtained in other cases of extremely inhomogeneous distribution. Retrospective dosimetry needs to be optimized and further developed in order to be able to deal with real exposure cases, where a mixture of both external and internal exposures will be encountered most of the times.BACKGROUND This study aims to analyze risk factors, clini
Like
Comment
Share
